Blogs

I'm still tapering from medications, but I am better, which is how I know recovery is possible. Understanding the systems that were impacted by medications was an essential piece of the puzzle.

On the pharmaceutical industry's spinning of results of clinical trials to hide suicide attempts and deaths on depression pills.

On a misleading Cochrane review of benzodiazepines for acute psychosis, and how Cochrane responded to criticism.

Peter Gøtzsche continues the discussion of the pharmaceutical industry’s manipulation of depression pill trials for children and adolescents.

We need to dig deeper into the doctors who conduct these evaluations, who hide behind their sealed documents with no transparency and zero accountability.

Providing the sole "no" vote on the approval of Rexulti, the consumer representative on the FDA's advisory committee shares her reasoning.

In 2012, in a period of low mood and anxiety, my GP prescribed an antidepressant. Little did I know that this would derail my life.

Western culture has instilled the idea that women are inherently weak and must trust authoritative doctors to manage their distress for them.

Discussing how depression pills don’t work for children and increase their risk of suicide.

Rob Wipond’s exposé details the vast net the psychiatric industry has cast over society under the guise of “trying to help.”

Although I experience distress acutely, I don’t have a disease, a bug, or an error. I have a body. When my circumstances are untenable, my body protests.

An interview with Elianna, who lives in Colorado with her son, Brandon, 34. His many diagnoses and misdiagnoses include autism and schizophrenia.

On the latest fad, ketamine, and how depression pills cause dependence and withdrawal.

One cause of fragility? Pathologizing our children with psychiatric diagnoses and focusing on a medical solution to life's problems.

Heather Armstrong’s life was taken by psychiatry, and our unwillingness to scrutinize their methods of madness.

Soteria-style community houses are a proven, viable, cost effective alternative to traditional psychiatric hospitals.

Peter Gøtzsche discusses misleading statements about depression pills and dosing.

My research into psychiatry began in late 2016 after being admitted to a mental "health" facility. There was nothing healthy about that experience!

Preying on the privatisation of distress comes the medical-industrial complex perverting the mental health landscape.

On the drug industry’s influence in defining disorders and the lack of efficacy for depression pills.

"I see the white paper as the culmination of my 40+ years of advocacy for people subjected to psychiatric incarceration and forced drugging."

In the spirit of the thinking behind the DSM, I have worked out a test for a new disorder for those who don't meet criteria for anything else.

Many enthusiasts of heavy metal will say things like "Heavy metal saved my life," and there is a fairly established narrative amongst fans of the wellbeing benefits.

Discussing the damage psychosis pills cause to the brain, and how that manifests in many clinical harms, like tardive dyskinesia.

In JAMA Psychiatry, the authors claimed we have no way to assess outcomes, and no way to know whether outcomes are "continuing to improve."